Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.690
-0.070 (-1.86%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Apyx Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 52.84 | 48.1 | 52.35 | 44.51 | 48.52 | Upgrade
|
| Revenue Growth (YoY) | 9.86% | -8.11% | 17.61% | -8.26% | 75.08% | Upgrade
|
| Cost of Revenue | 19.8 | 18.74 | 18.59 | 15.38 | 14.92 | Upgrade
|
| Gross Profit | 33.04 | 29.36 | 33.76 | 29.13 | 33.6 | Upgrade
|
| Selling, General & Admin | 36.12 | 43.13 | 48.27 | 47.9 | 43.73 | Upgrade
|
| Research & Development | 3.37 | 5.08 | 5.44 | 4.54 | 4.32 | Upgrade
|
| Operating Expenses | 39.49 | 48.21 | 53.71 | 52.44 | 48.05 | Upgrade
|
| Operating Income | -6.45 | -18.85 | -19.95 | -23.31 | -14.45 | Upgrade
|
| Interest Expense | -5.59 | -5.91 | -2.48 | -0.02 | -0.01 | Upgrade
|
| Interest & Investment Income | 1.11 | 1.61 | 0.92 | 0.16 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.09 | -0.16 | 0.62 | 0.51 | -0.37 | Upgrade
|
| EBT Excluding Unusual Items | -10.84 | -23.31 | -20.89 | -22.66 | -14.82 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 2.69 | - | - | Upgrade
|
| Legal Settlements | - | - | - | -0.25 | - | Upgrade
|
| Other Unusual Items | - | - | -3.09 | - | - | Upgrade
|
| Pretax Income | -10.84 | -23.31 | -21.28 | -22.91 | -14.82 | Upgrade
|
| Income Tax Expense | 0.27 | 0.25 | -2.43 | 0.37 | 0.38 | Upgrade
|
| Earnings From Continuing Operations | -11.11 | -23.56 | -18.85 | -23.28 | -15.2 | Upgrade
|
| Net Income to Company | -11.11 | -23.56 | -18.85 | -23.28 | -15.2 | Upgrade
|
| Minority Interest in Earnings | -0.11 | 0.1 | 0.14 | 0.09 | 0.03 | Upgrade
|
| Net Income | -11.21 | -23.46 | -18.71 | -23.18 | -15.17 | Upgrade
|
| Net Income to Common | -11.21 | -23.46 | -18.71 | -23.18 | -15.17 | Upgrade
|
| Shares Outstanding (Basic) | 41 | 36 | 35 | 35 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 41 | 36 | 35 | 35 | 34 | Upgrade
|
| Shares Change (YoY) | 15.62% | 2.66% | 0.31% | 0.54% | 0.35% | Upgrade
|
| EPS (Basic) | -0.27 | -0.66 | -0.54 | -0.67 | -0.44 | Upgrade
|
| EPS (Diluted) | -0.27 | -0.66 | -0.54 | -0.67 | -0.44 | Upgrade
|
| Free Cash Flow | -9.12 | -18.77 | -5.78 | -21.29 | -11.17 | Upgrade
|
| Free Cash Flow Per Share | -0.22 | -0.53 | -0.17 | -0.62 | -0.33 | Upgrade
|
| Gross Margin | 62.53% | 61.04% | 64.49% | 65.45% | 69.26% | Upgrade
|
| Operating Margin | -12.20% | -39.18% | -38.11% | -52.38% | -29.78% | Upgrade
|
| Profit Margin | -21.21% | -48.78% | -35.75% | -52.09% | -31.27% | Upgrade
|
| Free Cash Flow Margin | -17.25% | -39.02% | -11.04% | -47.83% | -23.03% | Upgrade
|
| EBITDA | -5.79 | -18.25 | -19.26 | -22.42 | -13.55 | Upgrade
|
| EBITDA Margin | -10.96% | -37.93% | -36.79% | -50.38% | -27.92% | Upgrade
|
| D&A For EBITDA | 0.66 | 0.6 | 0.69 | 0.89 | 0.9 | Upgrade
|
| EBIT | -6.45 | -18.85 | -19.95 | -23.31 | -14.45 | Upgrade
|
| EBIT Margin | -12.20% | -39.18% | -38.11% | -52.38% | -29.78% | Upgrade
|
| Advertising Expenses | 1.6 | 1.3 | 1.8 | 2.3 | 1.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.